BRIEF published on 07/11/2024 at 13:05, 2 years 3 months ago CureVac met à jour les dates des procès pour les litiges en matière de brevets contre Pfizer/BioNTech CureVac Contentieux Des Brevets Pfizer/BioNTech Dates Du Procès Mise À Jour Juridique
PRESS RELEASE published on 07/11/2024 at 13:00, 2 years 3 months ago CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech CureVac provides trial date updates for patent litigation against Pfizer/BioNTech in multiple geographies, including the U.S., UK, and Germany BioNTech CureVac Patent Litigation Pfizer Trial Dates
BRIEF published on 07/03/2024 at 08:17, 2 years 4 months ago CureVac Announces Strategic Restructuring to Focus on High-Value mRNA Opportunities Licensing Agreement MRNA Technology Oncology Research Strategic Restructuring Workforce Reduction
BRIEF published on 07/03/2024 at 08:17, 2 years 4 months ago CureVac annonce une restructuration stratégique pour se concentrer sur les opportunités d'ARNm de grande valeur Recherche En Oncologie Technologie ARNm Restructuration Stratégique Réduction Des Effectifs Contrat De Licence
BRIEF published on 07/03/2024 at 08:14, 2 years 4 months ago GSK and CureVac to Restructure Collaboration into New Licensing Agreement Licensing Agreement GSK CureVac MRNA Vaccines
BRIEF published on 07/03/2024 at 08:14, 2 years 4 months ago GSK et CureVac vont restructurer leur collaboration dans le cadre d'un nouvel accord de licence GSK CureVac Vaccins Contrat De Licence ARNm
PRESS RELEASE published on 07/03/2024 at 08:12, 2 years 4 months ago CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities CureVac initiates strategic restructuring to focus on high-value mRNA pipeline opportunities, including workforce reduction and new GSK agreement Oncology Strategic Restructuring CureVac MRNA Pipeline GSK Agreement
PRESS RELEASE published on 07/03/2024 at 08:09, 2 years 4 months ago GSK and CureVac to Restructure Collaboration into New Licensing Agreement GSK and CureVac restructure collaboration into new licensing agreement for mRNA vaccines development, manufacturing, and commercialization globally Licensing Agreement Collaboration GSK MRNA Vaccines CureVac
BRIEF published on 06/24/2024 at 22:10, 2 years 4 months ago CureVac Announces Voting Results of General Meeting Annual General Meeting Voting Results Board Appointments CureVac MRNA
BRIEF published on 06/24/2024 at 22:10, 2 years 4 months ago CureVac annonce les résultats du vote de l'assemblée générale Assemblée Générale Annuelle Nominations Au Conseil CureVac Résultats Du Vote ARNm
Published on 11/05/2026 at 15:20, 31 minutes ago MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors
Published on 11/05/2026 at 14:31, 1 hour 20 minutes ago First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile
Published on 11/05/2026 at 14:25, 1 hour 26 minutes ago Polaris Renewable Energy Announces Q3 2026 Results
Published on 11/05/2026 at 14:20, 1 hour 31 minutes ago Polaris Renewable Energy Declares Quarterly Dividend
Published on 11/05/2026 at 14:15, 1 hour 36 minutes ago Loar Holdings Inc. Reports Q3 2026 Record Results and Upward Revision to 2026 Outlook and Full Year 2027 Outlook
Published on 11/05/2026 at 15:34, 16 minutes ago Finexity AG: NuWays and GBC confirm price targets following Capital Markets Day and 9-month figures, taking the share split into account
Published on 11/05/2026 at 15:10, 41 minutes ago Center for Creative Leadership Names Patrick Mullane President and Chief Executive Officer
Published on 11/05/2026 at 14:58, 53 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 11/05/2026 at 15:01, 50 minutes ago Chiffre d'Affaires du 1er semestre de l'exercice 2026/2027
Published on 11/05/2026 at 10:16, 5 hours 35 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 10:16, 5 hours 35 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
